Citation Impact
Citing Papers
Markov Chain Monte Carlo Convergence Diagnostics: A Comparative Review
1996 Standout
Identification of a major co-receptor for primary isolates of HIV-1
1996 StandoutNature
Immunopathogenic Mechanisms of HIV Infection
1996 Standout
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Chronic Inflammation with Increased Human Immunodeficiency Virus (HIV) RNA Expression in the Vaginal Epithelium of HIV‐Infected Thai Women
2001 StandoutNobel
Effects of calcium ions on proteolytic processing of HIV‐1 gp160 precursor and on cell fusion
1994 StandoutNobel
Passive Immunotherapy in the Treatment of Advanced Human Immunodeficiency Virus Infection
1993
Challenge of Chimpanzees Immunized with a Recombinant Canarypox-HIV-1 Virus
1997 StandoutNobel
Phosphorothioate analogs of 2',5'-oligoadenylate. Enzymic synthesis, properties, and biological activities of 2',5'-phosphorothioates from adenosine 5'-O-(2-thiotriphosphate) and adenosine 5'-O-(3-thiotriphosphate)
1987 StandoutNobel
Expansion and Molecular Evolution of the Interferon-Induced 2′–5′ Oligoadenylate Synthetase Gene Family
2000
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
1993 StandoutNature
Virus-induced cell death in plants expressing the mammalian 2′,5′ oligoadenylate system
1996
Phosphorothioate analogs of 2',5'-oligoadenylate. Activation of 2',5'-oligoadenylate-dependent endoribonuclease by 2',5'-phosphorothioate cores and 5'-monophosphates
1987 StandoutNobel
Phosphorothioate analogs of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease
1987 StandoutNobel
Longitudinal and Cross‐Sectional Analysis of Cytotoxic T Lymphocyte Responses and Their Relationship to Vertical Human Immunodeficiency Virus Transmission
1998
A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8
1995
Anti-HIV activity of a glycoprotein from first trimester placental tissue
2002
Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission.
1994
Building Antibodies from their Genes
1992 StandoutNobel
By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling
1992 StandoutNobel
A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform 1 1Edited by M. Yaniv
1997 StandoutNobel
Selection of phage antibodies by binding affinity
1992 StandoutNobel
Antiviral Antibody Responses and Intrauterine Transmission after Primary Maternal Cytomegalovirus Infection
1995
Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infection
1991
Correlation of Genetic and Serologic Approaches to HIV-1 Subtyping in Thailand
1996
2- and 8-Azido photoaffinity probes. 1. Enzymic synthesis, characterization and biological properties of 2- and 8-azido photoprobes of 2-5A and photolabeling of 2-5A binding proteins
1988 StandoutNobel
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Prevention of HIV Infection by Passive Immunization with HIV Immunoglobulin
1991
The TNF and TNF Receptor Superfamilies
2001 Standout
Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus
2006 StandoutNobel
Guiding the Selection of Human Antibodies from Phage Display Repertoires to a Single Epitope of an Antigen
1994 StandoutNobel
Selection of Maternal Human Immunodeficiency Virus Type 1 Variants in Human Placenta
1999 StandoutNobel
Transgenic Potato Plants Expressing Mammalian 2′–5′ Oligoadenylate Synthetase are Protected From Potato Virus X Infection Under Field Conditions
1993
Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity
1992
Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.
1996 StandoutNobel
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
1991 StandoutNobel
Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.
1991
Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain
1991
2',5'-Oligoadenylates chiral at phosphorus: enzymic synthesis, properties, and biological activities of 2',5'-phosphorothioate trimer and tetramer analogs synthesized from (SP)-ATP.alpha.S
1985
Pivoting the Plant Immune System from Dissection to Deployment
2013 StandoutScience
HOW CELLS RESPOND TO INTERFERONS
1998 Standout
Cell-to-Cell Contact Results in a Selective Translocation of Maternal Human Immunodeficiency Virus Type 1 Quasispecies across a Trophoblastic Barrier by both Transcytosis and Infection
2001 StandoutNobel
Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination
1999 Standout
Biological activities of phosphodiester linkage isomers of 2-5A.
1983
Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies
2007 StandoutNobel
Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission
1996
Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160
1993 StandoutNobel
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
1991
Hierarchical Bayes Models for the Progression of HIV Infection Using Longitudinal CD4 T-Cell Numbers
1992
Antiviral Actions of Interferons
2001 Standout
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission
1995
Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts.
1991
Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant
1990 Science
Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1
1995
CELLULAR RESPONSES TO INTERFERON-γ
1997 Standout
Activation of 2-5A-dependent RNase by analogs of 2-5A (5'-O-triphosphoryladenylyl(2'—-5')adenylyl(2'—-5')adenosine ) using 2',5'-tetraadenylate (core)-cellulose.
1986
Stereoconfiguration markedly affects the biochemical and biological properties of phosphorothioate analogs of 2-5A core, (A2'p5')2A.
1986
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans
1993
Genetically Related Human Immunodeficiency Virus Type 1 in Three Adults of a Family with No Identified Risk Factor for Intrafamilial Transmission
1998 StandoutNobel
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
1994 Standout
Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus
1995
A mammalian 2-5A system functions as an antiviral pathway in transgenic plants.
1996
Amino acid changes in the fourth conserved region of human immunodeficiency virus type 2 strain HIV-2ROD envelope glycoprotein modulate fusion
1993 StandoutNobel
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
1993 StandoutNobel
Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro
1994 StandoutNobel
Impact of the Placental Cytokine-Chemokine Balance on Regulation of Cell-Cell Contact-Induced Human Immunodeficiency Virus Type 1 Translocation across a Trophoblastic Barrier In Vitro
2005 StandoutNobel
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
1995 StandoutNobel
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
1998 StandoutScience
Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population
1995
Protein Radicals in Enzyme Catalysis
1998 Standout
Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1
1992 StandoutNobel
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Inhibition of protein synthesis by the cordycepin analog of (2′–5′)ppp(Ap)nA, (2′–5′)ppp(3′dAp)n3′ dA, in intact mammalian cells
1983
Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous.
1990
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma.
1995 StandoutNobel
Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160
1992 StandoutNobel
Dendritic Cells, Infected with Vesicular Stomatitis Virus-Pseudotyped HIV-1, Present Viral Antigens to CD4+ and CD8+ T Cells from HIV-1-Infected Individuals
2000 StandoutNobel
LAV Revisited: Origins of the Early HIV-1 Isolates from Institut Pasteur
1991 StandoutScienceNobel
Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system.
1992 StandoutNobel
Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection
1993
Works of Yair Devash being referenced
The antiviral factor (AVF) from virus-infected plants induces discharge of histidinyl-TMV-RNA
1981
C-Terminal Fragments of gpl20 and Synthetic Peptides from Five HTLV-III Strains: Prevalence of Antibodies to the HTLV-III-MN Isolate in Infected Individuals
1990
Human leukocyte interferon and the antiviral factor (AVF) from virus-infected plants stimulate plant tissues to produce nucleotides with antiviral activity
1983
[100] Measurement of effect of (2′-5′)-oligoadenylates and analogs on tobacco mosaic virus replication
1986
Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain.
1990
Plant oligoadenylates: enzymic synthesis, isolation, and biological activities
1985
Enzymatic synthesis of the 2′,5′-A4 tetramer analog, 2′,5′-ppp3′dA(p3′dA)3, by rabbit reticulocyte lysates: Binding and activation of the 2′,5′-An dependent nuclease, hydrolysis of mRNA, and inhibition of protein synthesis
1983
Multiplication of Tobacco Mosaic Virus in Tobacco Leaf Disks Is Inhibited by (2′-5′) Oligoadenylate
1982 Science
[99] Enzymatic synthesis of plant oligoadenylates in vitro
1986
5'-dephosphorylated 2',5'-adenylate trimer and its analogs. Inhibition of tobacco mosaic virus replication in tobacco mosaic virus-infected leaf discs, protoplasts, and intact tobacco plants.
1984